Abstract
Renal transplantation (RT) recipients are at a high risk of developing tuberculosis (TB) following transplantation. Effectiveness of isoniazid (INH) in preventing TB is well documented in immunocompetent as well as immunocompromised persons. There is paucity of data on role of INH prophylaxis in RT recipients. Thus, a prospective randomised trial of INH in RT recipients was carried out to determine the efficacy of daily INH monotherapy in the prevention of TB in these patients. Patients of end stage renal disease (ESRD) taken for RT formed the subjects of study. Patients with active TB and active hepatitis at the time of RT were excluded from the study. Patients were randomised to receive INH 300 mg with pyridoxine 20 mg daily from the day of RT. The duration of the treatment was planned for 1 year or till the development of TB, which ever was earlier. Between October 1998 and September 2000, 114 RT were done at our hospital. Of these, 24 (21%) patients had active TB at the time of RT and thus were excluded. Patients included were randomised with 1:2 ratio of treatment and control group. Of the 90 patients thus enrolled, 30 were randomised in treatment group and 60 in control group. Of the included patients five patients had very early graft loss (three in treatment and two in control group) within days and thus excluded from the analysis. Three of the 27 (11.1%) patients in treatment group and 15 (25.8%) in control group developed TB (P = 0.10). The risk ratio of (RR) of INH versus control group of TB was 0.36 (95% CI, 0.10–1.32) but the difference was not statistically significant (P = 0.12). Only one patient developed INH induced hepatitis. In conclusion, with INH prophylaxis, there was a trend towards protection from TB, though it was not statistically significant. Further, all patients tolerated INH and hepatotoxicity was not a major problem in this group of patients.
Similar content being viewed by others
References
American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000: 161(suppl.) S221–S247.
FA Drobniewski J Ferguson (1996) ArticleTitleTuberculosis in renal transplant unit. Nephrol Dial Transplant 11 768–770
MM Hussein N Bakir H. Roujouleh (1990) ArticleTitleTuberculosis in patients undergoing maintenance dialysis Nephrol Dial Transplant 5 584
N Singh DL Paterson (1998) ArticleTitleMycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 27 1266–1277
A Naqvi F Akhtar R Naqvi et al. (1997) ArticleTitleProblems in diagnosis and treatment of tuberculosis in renal allograft recipients. Transplant proc 29 3051–3052
KK Malhortra SC Dash IK Dhawan et al. (1986) ArticleTitleTuberculosis and renal transplantation-observations from an endemic area of tuberculosis. Post Grad Med J 62 359–362
SK Agarwal SC Dash SC Tiwari et al. (1992) ArticleTitleSpectrum of tuberculosis in renal transplant recipients in North India. Ind J Nephrol 12 39–43
SK. Agarwal (2001) Tuberculosis in chronic renal failure SK Sharma A Mohan (Eds) et al. Tuberculosis Jaypee Brothers Medical Publishers New Delhi 338–347
V Sakhuja V Jha PP Varma et al. (1996) ArticleTitleThe high incidence of tuberculosis among renal transplant recipients in India. Transplantation 61 211–215
V Jha V Sakhuja D Gupta et al. (1999) ArticleTitleSuccessful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int 56 1944–1950
S Hariharan S Date G Gopalakrishnan et al. (1987) Tuberculosis after renal transplantation Dial Transplant 16 311–312
GT John L Vincet L Jeyaseelan et al. (1994) ArticleTitleCyclosporine immunosuppression and mycobacterial infections. Transplantation 58 247–248
GT John V Shankar AM Abraham et al. (2001) ArticleTitleRisk factors for post transplant tuberculosis. Kidney Int 60 1148–1153
PA Thomas MA. Manko (1975) ArticleTitleChemoprophylaxis for prevention of tuberculosis in the immunosuppressed renal allograft patients Transplantation 20 76
International Union against Tuberculosis Committee on Prophylaxis Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow up in the IUAT trial. Bull WHO 1982; 60: 555–564.
SH Ferebee (1970) ArticleTitleControlled chemoprophylaxis trial in tuberculosis: a general review. Adv tuberc res 17 28–106
JW Pape SS Jean JL Ho et al. (1993) ArticleTitleEffect of isoniazid prophylaxis on incidence of active TB and progression of HIV infection. Lancet 342 268–272
CC Whalen JL Johnson A Okwera et al. (1997) ArticleTitleA trial of three regimens to prevent tuberculosis in Ugandon adults infected with HIV. N Engl J Med 337 801–808
MP Hawken HK Meme LC Elliot et al. (1997) ArticleTitleIsoniazid preventive therapy for tuberculosis in HIV-I infected adults: results of a randomized controlled trial. AIDS 11 875–882
DL Cohn WM. El-Sadr (2000) Treatment of latent tuberculosis infection LB Reichman E Hershfield (Eds) Tuberculosis: A comprehensive International Approach EditionNumber2nd edn. Marcel Dekker New York 471–502
A Yildiz MS Sever A Turkmen et al. (1998) ArticleTitleTuberculosis after renal transplantation: experience of one Turkish Centre. Nephrol Dial Transplant 13 1872–1875
RK Spence DC Dafoe G Rabin et al. (1983) ArticleTitleMycobecterial infections in renal allograft recipients. Arch Surg 118 356–359
RM Higgins AP Cahn D Porter et al. (1991) Mycobacterial infections after renal transplantation Q J Med 78 145–153
S Apaydin MR Altiparmak K Serdengecti et al. (2000) ArticleTitleMycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 32 501–505
A Mwinga M Hosp P Godfrey-Faussett et al. (1998) ArticleTitleTwice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 12 2447–2457
FM Gordin JP Matts C Miller et al. (1997) ArticleTitleA controlled trial of isoniazid in persons with anergy and HIV infection who are at high risk for tuberculosis. N Engl J Med 337 315–320
SL Anatony C Ynares JS Dummer (1997) ArticleTitleIsoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 11 34–37
HC Bucher LE Griffith GH Guyatt et al. (1999) ArticleTitleA meta - analysis of randomized controlled trials. AIDS 13 501–507
MA Espinal PHA Laszlo L Simonsen et al. (2001) ArticleTitleGlobal trends in resistance to antitubercular drugs. N Engl J Med 344 1294–1303
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agarwal, S.K., Gupta, S., Dash, S.C. et al. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 36, 425–431 (2004). https://doi.org/10.1007/s11255-004-6251-6
Issue Date:
DOI: https://doi.org/10.1007/s11255-004-6251-6